Indeed, two independent research groups have put forward compelling arguments that degenerating or regenerating skeletal muscle is the likely source of the cTnT elevation in neuromuscular disorders, including ALS.4 This evidence concerns the gene TNNT2 and amyotrophic lateral sclerosis.